US-based biotechnology firm KnipBio has announced it has successfully completed its series B funding round, inteneded to further the development of its single cell protein research. Read more >>
Treatment with Corbus Pharmaceuticals’ investigative therapy lenabasum (formerly known as anabasum) significantly improves the symptoms of diffuse cutaneous systemic…
read moreRespiratory Motion, Inc. (Waltham, Massachusetts, USA) the global leader in minute ventilation monitoring and Corestone Biosciences Co., Ltd., an…
read moreEleven companies will be honoured at the Nova Scotia Export Achievement Awards on June 12, including Spring Loaded Technology….
read moreSiamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer therapeutics, today announced that Jeff Behrens, president and chief executive…
read moreRegroup Mass Notification, the award-winning leader in emergency and day-to-day mass communication technology, today announced that it is joining…
read moreIf you walk into Carbonite CEO Mohamad Ali’s office, you might notice a large white board diagram. Take a…
read moreCarbonite, Inc. (NASDAQ:CARB) a leading provider of data protection solutions for businesses and the IT professionals who serve them,…
read moreWasabi Technologies, Inc. Chief Executive Officer David Friend discusses how the company is taking on Amazon.com in cloud storage….
read moreFutureFuel.io, a SaaS platform connecting employers, employees, and student loan servicers, is pushing to “crush” student debt. Read more…
read moreEmovi, Inc. announced today they have received the support of the Quebec government with financial assistance of $4.8 million…
read more